Latest Stories
Intra-Cellular Sues to Stop 7 Copies of Its Only Drug, Caplyta
Intra-Cellular Therapies Inc. filed lawsuits seeking to block copies of Caplyta proposed by Sandoz Group and six other generic-drug makers, alleging infringement of as many as 16 patents for the bipolar depression and schizophrenia treatment.
Teva Hits Amarin With Antitrust Lawsuit Over Generic Competition
Teva Pharmaceuticals is challenging Amarin Pharma Inc., alleging it entered exclusive agreements with active pharmaceutical ingredient suppliers to maintain exclusivity and exclude or delay potential competitors to its drug Vascepa.
Medicare Proposes Rate Hikes for Nursing Homes, Hospices
Nursing homes, hospice providers, and inpatient psychiatric facilities would all see Medicare pay hikes next year under proposals released Thursday by the Biden administration.
Liquidia Can Launch Yutrepia Lung-Disease Drug, a Blow to UTC
Liquidia Corp. can launch its Yutrepia lung-disease drug after a Delaware federal judge agreed to remove part of his 2022 judgment blocking final approval, a blow to
Medtronic Shakes Investor Claims Over Insulin Pump Problems
Medtronic PLC investors failed to state claims for security fraud tied to the device maker’s statements about allegedly flawed models of its MiniMed insulin pumps, a federal court ruled Thursday.
Professor Wins Some Covid-Based Bias Claims Over In-Person Rule
Pennsylvania’s Kutztown University violated disability discrimination law when it repeatedly denied a business professor’s requests to teach remotely as an accommodation for an eye condition that left her at greater risk from the Covid-19 virus, a federal judge ruled.
Florida Man Pleads Guilty to Role in $4.6 Million Kickback Scam
A Florida man has admitted his role in a $4.6 million Medicare kickback and bribe conspiracy, according to the Justice Department Thursday.
Becton Dickinson Worker Mostly Advances Discrimination Lawsuit
A former
Amgen Faces Partial Setback in Patent Ruling on Leukemia Drug
PRACTITIONER INSIGHTS
View More InsightsEXPLORE BLOOMBERG LAW
Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas: